Cholinesterase activity after treatment with mebendazole, thiabendazole and metronidazole in patients with various parasitic diseases.
D001562:Benzimidazoles / Q000627:therapeutic use*; D002802:Cholinesterases / Q000378:metabolism*; D006801:Humans; D008463:Mebendazole / Q000627:therapeutic use*; D008795:Metronidazole / Q000627:therapeutic use*; D010272:Parasitic Diseases / Q000188:drug therapy; D013827:Thiabendazole / Q000627:therapeutic use*
D001562:Benzimidazoles; D008795:Metronidazole; D008463:Mebendazole; D002802:Cholinesterases; D013827:Thiabendazole